A systematic review and meta-analysis published in Diabetes, Obesity & Metabolism examined the effects of various weight loss interventions on fat-free mass (FFM) in adults with overweight or obesity. The study included randomized controlled trials published between 2015 and October 21, 2025, focusing on individuals achieving at least a 10% reduction in total body weight through diet and exercise, incretin-based therapies, or bariatric surgery. Body composition had to be measured by DXA, CT, or MRI rather than by bathroom-scale estimates. Twelve diet-and-exercise trials, five incretin-based therapy trials, and four bariatric surgery trials were pooled, n = 1334 participants in total.
Findings on fat-free mass loss showed that diet and exercise interventions resulted in a pooled loss of 1.8 kg (about 4 lb) of FFM (95% CI: −2.6 to −1.0 kg). Incretin-based therapies produced a loss of 4.8 kg (about 10.6 lb; 95% CI: −5.6 to −3.9) compared with placebo, and bariatric surgery the largest at 9.1 kg (about 20 lb; 95% CI: −12.3 to −6.0). Expressed as a share of all the weight lost, fat-free mass accounted for 14.9% with diet with or without exercise — 22.3% for diet alone, but only 7.7% when exercise was added — against 33.3% for incretin-based therapies and 34.2% after surgery.
Implications for weight loss strategies. The gap between 7.7% and 34.2% is the finding worth carrying away: every route to a 10% weight loss costs some fat-free mass, but the size of that bill depends heavily on the route — and, within the diet arm, on whether exercise came with it. One caveat the authors are explicit about: these were separate trials pooled by category, not a head-to-head comparison, so the modalities were tested in different populations under different protocols.
Practical takeaways from the study emphasize the importance of incorporating exercise into any weight loss regimen. While diet alone can lead to weight loss, combining it with physical activity can help mitigate the loss of muscle mass. This is particularly relevant for individuals with obesity or those managing type 2 diabetes, who may be more susceptible to losing muscle during weight loss.
The bottom line is that strategies aimed at weight loss should prioritize the preservation of fat-free mass. Exercise should be a cornerstone of any weight loss approach, particularly for those undergoing pharmacological or surgical interventions that may lead to greater muscle loss.
Medical note. This article is intended for general educational purposes and should not be considered personal medical advice.